Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations

Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182

Metagenomic analysis of coastal Kenya female Aedes aegypti mosquito RNA metaviromes reveal presence of diverse insect specific viruses

Omuoyo D. et al, (2023)

Metagenomic analysis of coastal Kenya female Aedes aegypti mosquito RNA metaviromes reveal presence of diverse insect specific viruses

Omuoyo D. et al, (2023)

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

Hamaluba M. et al, (2023), Wellcome open research, 8

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis

Nyamwaya DK. et al, (2022), PLOS Global Public Health, 2, e0000914 - e0000914

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2022), Wellcome Open Research, 6, 127 - 127

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.

Nyamwaya DK. et al, (2022), PLoS medicine, 19

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2022)

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya

Orangi S. et al, (2022)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.

Nyagwange J. et al, (2022), Wellcome open research, 7

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Etyang AO. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74, 288 - 293

Using cross-species vaccination approaches to counter emerging infectious diseases.

Warimwe GM. et al, (2021), Nature reviews. Immunology, 21, 815 - 822

COVID-19 transmission dynamics underlying epidemic waves in Kenya.

Brand SPC. et al, (2021), Science (New York, N.Y.), 374, 989 - 994

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence among Truck Drivers and Assistants in Kenya

Kagucia EW. et al, (2021), Open Forum Infectious Diseases, 8

Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya

Orangi S. et al, (2021)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Adetifa IMO. et al, (2021), Nature communications, 12

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2021), Wellcome Open Research, 6, 127 - 127

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels

Bottomley C. et al, (2021)

Load More

Include forthcoming?